Mumbai : Aries Agro Limited, a leading player in the micronutrient fertilisers and plant nutrition solutions segment, has reported a strong financial performance for the quarter ended June 30, 2026, with significant improvement in both revenue and profitability.
Consolidated Net Income from Operations stood at ₹185.86 crore for Q1 FY27, compared with ₹159.79 crore in the corresponding quarter of the previous financial year, registering a growth of approximately 16.3% year-on-year.
Consolidated Profit After Tax (PAT) attributable to owners stood at ₹14.91 crore, compared with ₹10.03 crore in Q1 FY26, marking a strong 48.7% year-on-year growth. Consolidated Total Comprehensive Income attributable to owners stood at ₹14.18 crore, compared with ₹10.18 crore in the corresponding period last year.
On a standalone basis, Aries Agro reported Net Income from Operations of ₹180.83 crore, against ₹154.19 crore in Q1 FY26, representing a growth of approximately 17.3%. Standalone PAT stood at ₹13.62 crore, compared with ₹9.17 crore in Q1 FY26, reflecting a growth of approximately 48.5%.
Commenting on the performance, Dr. Rahul Mirchandani, Chairman & Managing Director, Aries Agro Limited, said “The performance in the first quarter reflects the strength and resilience of our business, supported by our focus on innovative plant nutrition solutions and our extensive reach across the agricultural ecosystem. The improvement in profitability alongside revenue growth is encouraging and reflects our continued focus on operational efficiency and value creation.”
The Company continues to focus on strengthening its portfolio of micronutrient fertilisers and plant nutrient solutions while expanding its reach across markets and agricultural communities.
Aries Agro’s business is inherently influenced by cropping patterns, seasonality and weather conditions. As a result, quarterly performance may not necessarily be representative of the full-year performance.
The financial results for the quarter ended June 30, 2026 were reviewed and recommended by the Audit Committee and approved by the Board of Directors at its meeting held on August 11, 2026. The Statutory Auditors have carried out a Limited Review of the results.
